Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (4) , 449-452
- https://doi.org/10.1016/0959-8049(94)90416-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1991
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1991
- Prognostic factors in advanced epithelial ovarian cancerBritish Journal of Cancer, 1990
- An overview in the treatment of advanced ovarian cancerBritish Journal of Cancer, 1990
- Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survivalCancer, 1989
- Multidrug resistance in ovarian cancerCancer, 1987
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1984